Prof Alex Miras

About

Prof Alex Miras is an internationally renowned academic and clinician in the field of obesity. He has been caring for people living with obesity since 2010, contributed to national and international guidelines, and led cutting-edge research studies in the field.

"I believe in clear communication with patients so that they are fully aware of the facts regarding obesity care."On his approach to care

Currently working at Ulster University, Prof Miras provides educational leadership and teaching alongside research. He also works clinically at the Western Health and Social Care Trust, based at Altnagelvin Hospital, Derry, where he is a key contributor to the Department of Endocrinology. His research has been published in some of the most prestigious journals in the world and he has been invited to speak about his work at numerous international conferences.

People deserve access to world-renowned expertise when looking to manage obesity and weight issues. We are thrilled to have Prof Miras, an expert in the field of obesity medicine and science, as part of the BeyondBMI team.

Who I work with

A particular interest in patients with type 2 diabetes, and women with infertility or polycystic ovarian syndrome (PCOS).

Areas of expertise

• Obesity Medicine
• Endocrinology
• Pharmacotherapy (GLP-1 / medication management)
• Women's Health

Registrations & memberships

• Irish Medical Council (IMC) (no. 500519)
• General Medical Council (GMC)

Education

• FRCP, Royal College of Physicians London (2020)
• Fellow of the Higher Education Academy (2019)
• Certificates of Completion of Training (CCT) in Endocrinology, Diabetes and General Medicine (2014)
• PhD, Imperial College London (2013)
• MRCP, Royal College of Physicians London (2005)
• MBBS, University of London (2002)
• BSc in Endocrinology, Imperial College London, awarded with 2:1 (2000)

Research, media & recognition

Selected publications

• Samarasinghe SNS, Leca B, Alabdulkader S, et al., Miras AD. Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial. Lancet. 2024;403(10443):2489–2503.
• Miras AD, Kamocka A, Pérez-Pevida B, et al. The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study. Diabetes Care. 2020.
• Miras AD, Pérez-Pevida B, Aldhwayan M, et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(7):549–559.
• Miras AD, le Roux CW. Metabolic Surgery in a Pill. Cell Metab. 2017;25(5):985–987.
• Miras AD, le Roux CW. Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health. Lancet Diabetes Endocrinol. 2014;2(2):141–151.
• Miras AD, le Roux CW. Mechanisms underlying weight loss after bariatric surgery. Nature Reviews Gastroenterology and Hepatology. 2013;10(10):575–584.

Awards & appointments

• Clinical academic adviser to the NICE Weight Management Guideline Committee (2023–2025)
• Clinical academic adviser to the NICE Overweight and Obesity Management Quality Standards Committee (2023–2025)
• Lead for the Experimental Medicine research cluster, Ulster University (2025–)
• Co-chair, NIHR Clinical Research Network in Metabolic Research for Northern Ireland
• Member of the Clinical Committee of the Society for Endocrinology (2024–)
• Member of the British Obesity and Metabolic Specialist Society (BOMSS) council (2024–)
• Trustee and Chair of the Clinical Sub-Committee, Association for the Study of Obesity (2020–)
• Clinical adviser to the Northern Ireland regional obesity management strategy group (2022–)
• Member of the UK Obesity Management Collaborative (2023–)
• Member of the Endocrinology and Diabetes section, Royal Society of Medicine (2024–)
• SCOPE National Fellow for the UK (2017)